Navigation Links
Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
Date:9/17/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...evalent and smoking cessation less likely among pe...r (A.D.H.D.) In a study of smokers with attention...ibited elevated hyperactivity and impulsivity, wit...after 8 weeks than those with inattention symptoms...e study, now available online in Nicotine and Tob...
(Date:11/21/2008)...w inventions in computerized brain,training may h...s lead fuller,lives, said Jeff Zimman, Chairman o...today at the annual Technology Innovators Conferen...National Center for Technology Innovation to,prom... , Zimman said cognitive training programs ...
(Date:11/21/2008)...Newswire/ -- The U.S. Department of Health and Hum...fety Organizations (PSOs). , , The rule be...l requirements and procedures for PSOs, new entiti...s can work to collect, aggregate and analyze data ... and confidentiality protections - to identify and...
(Date:11/21/2008)... -- CVS Caremark today applauded the,Federal Trad... to address,issues of competition and continued i...c drugs. , "CVS Caremark serves millions of... to provide life-saving and life-enhancing treatme...creation of a federal legislative pathway,for FDA...
Breaking Medicine News(10 mins):Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:New Applications for Cognitive Training 2Health News:Final Rule Issued for Patient Safety Organizations 2Health News:Final Rule Issued for Patient Safety Organizations 3Health News:CVS Caremark Applauds FTC's Leadership on Follow-on Biologics 2
...Coburg, Melbourne, who is HIV positive, is in the ... been heaped on him//. The fear of using condoms l...h several male partners and thus became a transmit...tion has been slapped with 30 or more charges, whi...
... consumption of just one meal high in saturated fa... prevent// the ‘good cholesterol’, HDL, from prote...archers had also explained that not only does the ...HDLs), prevented, which is thought to be a main re...
...thousands displaced by the Israel-Hezbollah confli...e shortages of fuel// and drinking water amid fear...major setback - and with the fuel problems increas...acto blockade of the country," said a spokesperson...
...presence of drugs and not the intoxication or dama...ug mean it will affect their performance? // Proba...d Alcohol Research Centre. "With cannabis, for in...ent is from quite a long time ago (the drug remain...
Other Medicine News:Health News:Study Shows That The Quality Of HDL Produced Depends On The Food Consumed 2Health News:Lebanon Fears of Epidemics as the Crisis Deepens 2
(Date:11/20/2008)...., Nov. 20 Duska Therape...d today that it has submitted its,pivotal Phase 3... Special,Protocol Assessment (SPA) procedure with... Subject to securing an agreement with the FD...e, double-blind, placebo-controlled and randomized...
(Date:11/19/2008)...Nov. 19 Posit Science Corporation,... Society for Neuroscience,Annual Conference in Wa...training may benefit Baby Boomers. The computeriz...TM) uses adaptive exercises that target auditory a...to drive generalized,improvements in cognition by...
(Date:11/19/2008)...ov. 19 Isogen, a contract developm...lling, today announced the first,phase launch of ...ded to,specifically address the process, facility...he $2 billion highly-niched, low-volume clinical a...segment. , Companies can invest over $100 m...
(Date:11/18/2008)... Nov. 18 Forty-two lead... November national forum to consider cutting-edge ...h and national economy from outbreaks of dangerous...y. , , Among those innovations: , , ... kitchen table that detects highly contagious and ...
Breaking Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Isogen Launches Major New Facility to Address Global Biopharma Demand 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Scientists find missing evolutionary link using tiny fungus crystal 1761 1Scientists find missing evolutionary link using tiny fungus crystal 1761 2Smoking rate among New York City teens was lowest on record in 2007 8973 1Smoking rate among New York City teens was lowest on record in 2007 8973 2Smoking rate among New York City teens was lowest on record in 2007 8973 3Electronic switch opens doors in rheumatoid joints 1757 1Oral osteoporosis meds appear to reduce the risk of jaw degradation 8970 1Oral osteoporosis meds appear to reduce the risk of jaw degradation 8970 2
...Mich., March 27, 2007 /PRNewswire/ -- Afid,Therape...sults on,the ability of its new triple mode viral ...mammalian cells. The audited results were,obtained...ng,organization. The new viral sequestrating agent... critical mechanisms thus blocking,infection. They...
...012 coadministered with statins for only five week...ls achieved with,statins alone, with similarly fav...LEANS and CARLSBAD, Calif., March 26, 2007,/PRNews...unced new,results from its Phase 2 clinical trial ...ed today at the of Cardiology,Annual Scientific Se...
Other Medicine Technology:Afid Therapeutics Obtains Positive Evaluation of its Triple Mode,Viral Sequestration Agents 2Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 2Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 4Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 5Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 6Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 7Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 8Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 9
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: